HIND

Vyome Holdings, Inc

Nasdaq· Pharmaceutical Preparations· Inc. DE· CIK 0001427570 Biotech & Drug Discovery

$1.79 +0.00 (+0.00%)

Oct 26 4:00 PM ET · prev $1.79

Market cap

$12.6M

Nano cap

Consensus

Buy

89% Buy or better · 9 analysts

Median target

$8.00

+347% · range $3.50–15.00

Next earnings

Nov 12

in 17 days · EPS est. −$0.20

1 year

−67.6%

from $5.52 · Oct 27

30 days

−11.8%

from $2.03

52-week range

$1.79–6.31

−72% from high · low Oct 23

Avg volume 20D

9.3K

shares / day

Short interest

26.2K

≈0.4% of shares · +21.9%

Days to cover

1.0

at average volume

Insider net

no open-market trades · 12 mo

New fund stakes

Q2 2026 13F · 0 exits

SecBot read BEARISH 2 reports · latest

Balance 1 bearish · 1 bullish oldest → newest, height = score

Avg score

·High conf. 2/2 ·Next Earnings date, Nov 12, 2026

Strongest BEARISH Vyome Holdings reported Q1 2026 EPS of -$0.15, beating the consensus estimate of -$0.19 by 21%, but revenue…

All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

R Feb 25 Vyome Holdings (HIND) announced a strategic transaction where its su…
X Jul 31 Short interest falls 29.3% to 27.4K
A Sep 3 Chardan Capital initiates

Signal stack

Where each data set points today.

InsidersNO TRADES

No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
InstitutionsMIXED

Q2 2026: 0 added (0 new), 1 trimmed or exited.
AnalystsBULLISH

8 of 9 rate it Buy or better. Every target is above the price.
EstimatesRISING

Current-quarter EPS estimate −$0.210 → −$0.195 over 90 days.
Short sellersBUILDING

Short interest +21.9% to 26.2K shares. 1.0 days to cover, ≈0.4% of shares.
TrendDOWNTREND

13% below its 50-day average. New closing low $1.79 on Oct 26.

Who's buying

13F· Q2 2026

new positions

exits

Fund	Move	Shares	Value
UBS Group AG	TRIM	11,908	$25.6K
GEODE CAPITAL MANAGEMENT, LLC	DOUBLED	25,793	$55.5K
UBS Group AG	DOUBLED	22,675	$48.8K
CITIGROUP INC	DOUBLED	16	$34.00
UBS Group AG	DOUBLED	3,959	$13.6K
BANK OF AMERICA CORP /DE/	DOUBLED	16	$55.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts

Buy 89% rate it Buy or better

Strong Buy2Buy6Hold1Sell0Strong Sell0

12-month targets · 3 analysts

$1.79 $3.50 $8.00 $15.00

Price is below the lowest target. Median implies +347%.Targets as of Oct 26, 2026.

Recent actions

Date	Firm	Action	Rating
Sep 3, 2026	Chardan Capital INITIATE	INITIATE	Buy

Insider ledger

Form 4

open-market buys or sells · 12 mo

Date	Insider	Type	Value
Sep 1, 2026	Jolly Mohanjit Director	AWARD	120,000 sh

Earnings setup

Estimates

Nov 12

reports in 17 days

−$0.20

EPS estimate, this quarter

+7%

estimate change, 90 days

Current-quarter EPS estimate

−$0.210

90d

−$0.210

60d

−$0.210

30d

−$0.160

−$0.195

Now

Period	EPS est.	Range	30D rev.	Revenue
Current Q	-$0.20	-$0.23–-$0.16	+7.1%	$0.00
Next Q	-$0.20	-$0.23–-$0.16	+18.7%	$0.00
Current FY	-$0.65	-$0.86–-$0.52	+7.8%	$103.0K
Next FY	-$0.80	-$1.05–-$0.57	+12.9%	$200.0K